Anna Anderson

Dr. Ana Anderson, a leading immunology researcher at Harvard, joins to discuss her groundbreaking work on T-cell regulation in cancer. She highlights the promise of checkpoint inhibitors like PD-1 and CTLA-4, while addressing the need to remodel the tumor microenvironment for better outcomes. Anderson emphasizes the importance of targeting myeloid cells and the advancements in adoptive cell therapies. She also shares insights from her research on TCF1's role in T-cell function and the exciting future directions in immunotherapy. Plus, she reveals her personal passion for rowing!